Rabbit Recombinant Monoclonal ALAS2/ASB antibody. C-terminal. Suitable for IP, WB and reacts with Human, Mouse, Rat samples. Cited in 9 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IP | WB | |
---|---|---|
Human | Tested | Tested |
Mouse | Expected | Tested |
Rat | Expected | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/30 - 1/50 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 - 1/2000 | Notes - |
Species Rat | Dilution info 1/1000 - 1/2000 | Notes - |
Species Human | Dilution info 1/1000 - 1/2000 | Notes - |
Catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation of succinyl-CoA and glycine to form aminolevulinic acid (ALA), with CoA and CO2 as by-products (PubMed:14643893, PubMed:21252495, PubMed:21309041, PubMed:21653323, PubMed:32499479). Contributes significantly to heme formation during erythropoiesis (PubMed:2050125). Isoform 3. Catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation of succinyl-CoA and glycine to form aminolevulinic acid (ALA), with CoA and CO2 as by-products (PubMed:14643893). Catalytic activity is 75-85% of isoform 1 activity (PubMed:14643893). Isoform 4. Catalyzes the pyridoxal 5'-phosphate (PLP)-dependent condensation of succinyl-CoA and glycine to form aminolevulinic acid (ALA), with CoA and CO2 as by-products (PubMed:14643893). Catalytic activity is 65-75% of isoform 1 activity (PubMed:14643893).
ALASE, ASB, ALAS2, ALAS-E, 5-aminolevulinic acid synthase 2, Delta-ALA synthase 2, Delta-aminolevulinate synthase 2
Rabbit Recombinant Monoclonal ALAS2/ASB antibody. C-terminal. Suitable for IP, WB and reacts with Human, Mouse, Rat samples. Cited in 9 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
ALAS2 also known as 5-aminolevulinate synthase 2 is an important enzyme in heme biosynthesis. This enzyme is specific to erythroid cells and it catalyzes the first step in the formation of heme. ALAS2 has an approximate molecular weight of 65 kDa and it is mainly expressed in the mitochondria of erythroblasts in the bone marrow. It functions mechanistically by directing the condensation of glycine and succinyl-CoA to form delta-aminolevulinic acid (ALA) which is important for subsequent steps in heme production.
ALAS2 plays a significant role in erythropoiesis as it contributes to heme production which is necessary for hemoglobin assembly. ALAS2 is not known to be part of a complex per se but its function is regulated allosterically by iron availability and activity levels. The synthesis of heme is required for proper formation of red blood cells and ALAS2's regulatory mechanisms ensure that heme is synthesized in synchrony with iron levels.
ALAS2 acts as an initiator of the heme biosynthesis pathway which connects to the larger porphyrin metabolism pathway. This pathway involves additional proteins such as ferrochelatase and uroporphyrinogen III synthase. ALAS2's activity influences the overall efficiency of heme production and in turn iron metabolism. The regulation of ALAS2 by iron levels is a quintessential example of the coordination between cellular metabolism and iron availability in the erythroid lineage.
ALAS2 mutations associate with X-linked sideroblastic anemia a condition characterized by defective heme synthesis in erythroid cells. Relatedly heme biosynthesis dysregulation links to conditions like porphyria. In X-linked sideroblastic anemia malfunction of ALAS2 affects the activity of other enzymes involved in the heme production pathway leading to iron accumulation in mitochondria and ineffective erythropoiesis. Researchers also find connections between ALAS2 and proteins like ferrochelatase in the context of these disorders further impacting the understanding of heme-related diseases.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
ab184964 (Purified) at 1:30 dilution (2 µg) immunoprecipitating ALAS2/ASB in K-562 whole cell lysate.
Lane 1 (input): K-562 (Human chronic myelogenous leukemia lymphoblast) whole cell lysate 10 µg
Lane 2 (+): ab184964 & K-562 whole cell lysate
Lane 3 (-): Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab184964 in K-562 whole cell lysate
For western blotting, VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1:1000 dilution.
Blocking and diluting buffer: 5% NFDM/TBST.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab184964)
All lanes: Immunoprecipitation - Anti-ALAS2/ASB antibody [EPR15112(B)] - C-terminal (ab184964)
Predicted band size: 65 kDa
All lanes: Western blot - Anti-ALAS2/ASB antibody [EPR15112(B)] - C-terminal (ab184964) at 1/1000 dilution
Lane 1: NIH/3T3 (Mouse embryonic fibroblast) whole cell lysates at 15 µg
Lane 2: PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates at 15 µg
Lane 3: Rat brain lysates at 15 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 65 kDa
Observed band size: 65 kDa
Western blot analysis of immunoprecipitation pellet from 293 cell lysate immunoprecipitated using ab184964 at 1/50 dilution.
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated secondary used at a 1/1000 dilution.
All lanes: Immunoprecipitation - Anti-ALAS2/ASB antibody [EPR15112(B)] - C-terminal (ab184964)
Predicted band size: 65 kDa
All lanes: Western blot - Anti-ALAS2/ASB antibody [EPR15112(B)] - C-terminal (ab184964) at 1/1000 dilution
Lane 1: K562 lysate at 20 µg
Lane 2: Jurkat lysate at 20 µg
Lane 3: 293 lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 65 kDa
All lanes: Western blot - Anti-ALAS2/ASB antibody [EPR15112(B)] - C-terminal (ab184964) at 1/1000 dilution
All lanes: Human fetal liver at 10 µg
All lanes: Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 65 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com